Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma

NCT01106235 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Melanoma

Interventions

BIOLOGICAL: therapeutic autologous lymphocytes
BIOLOGICAL: aldesleukin
DRUG: cyclophosphamide
PROCEDURE: biopsy

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]